It rarely appears in the absence of mutations in IDH and ТР53, it is mutually exclusive to 1p/19q codeletion. It can be used for differentiation of astrocytomas and 1p/19q codeletion. The prognosis is more favorable in case of a loss of th ATRX activity. This evidence concerns the gene IDH2 and astrocytoma (excluding glioblastoma).